Peritoneal Dialysis and the Process of Modality Selection

Blake, Peter G.; Quinn, Robert R.; Oliver, Matthew J.

doi:10.3747/pdi.2012.00119

Cited by 74 publications

(85 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…RRF was not different between the incrPD group and the stPD group, so incrPD was not started at an earlier stage than stPD. It should be noted that to start with incrPD it is necessary to have a good pre-dialysis program and a timely initiation of dialysis; several studies have shown that a good pre-dialysis education program increases the prevalence of patients opting for self-care dialysis [19–25]. As far as adequacy is concerned, patients in both the incrPD group and the stPD group were always above the minimal targets of adequacy [2] even though, as expected, adequacy values were higher on stPD at the beginning of treatment (Table 2).…”

Section: Discussionmentioning

confidence: 99%

Incremental peritoneal dialysis: a 10 year single-centre experience

et al. 2016

View full text Add to dashboard Cite

IntroductionIncremental dialysis consists in prescribing a dialysis dose aimed towards maintaining total solute clearance (renal + dialysis) near the targets set by guidelines. Incremental peritoneal dialysis (incrPD) is defined as one or two dwell-times per day on CAPD, whereas standard peritoneal dialysis (stPD) consists in three-four dwell-times per day.Patients and methodsSingle-centre cohort study. Enrollement period: January 2002–December 2007; end of follow up (FU): December 2012. Inclusion criteria: incident patients with FU ≥6 months, initial residual renal function (RRF) 3–10 ml/min/1.73 sqm BSA, renal indication for PD.ResultsMedian incrPD duration was 17 months (I–III Q: 10; 30). There were no statistically significant differences between 29 patients on incrPD and 76 on stPD regarding: clinical, demographic and anthropometric characteristics at the beginning of treatment, adequacy indices, peritonitis-free survival (peritonitis incidence: 1/135 months-patients in incrPD vs. 1/52 months-patients in stPD) and patient survival. During the first 6 months, RRF remained stable in incrPD (6.20 ± 2.02 vs. 6.08 ± 1.47 ml/min/1.73 sqm BSA; p = 0.792) whereas it decreased in stPD (4.48 ± 2.12 vs. 5.61 ± 1.49; p < 0.001). Patient survival was affected negatively by ischemic cardiopathy (HR: 4.269; p < 0.001), peripheral and cerebral vascular disease (H2.842; p = 0.006) and cirrhosis (2.982; p = 0.032) and positively by urine output (0.392; p = 0.034). Hospitalization rates were significantly lower in incrPD (p = 0.021). Eight of 29 incrPD patients were transplanted before reaching full dose treatment.ConclusionsIncrPD is a safe modality to start PD; compared to stPD, it shows similar survival rates, significantly less hospitalization, a trend towards lower peritonitis incidence and slower reduction of renal function.

show abstract

Section: Discussionmentioning

confidence: 99%

Incremental peritoneal dialysis: a 10 year single-centre experience

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The DMAR system is a quality assurance system that prospectively measures baseline characteristics and outcomes, including modality changes, hospitalization, transplantation, treatment withdrawal, and death (10)(11)(12). Data are entered by trained clinical staff and reviewed every 90 days by the investigators (M.J.O.…”

Section: Study Design and Data Sourcesmentioning

confidence: 99%

Hospitalization Rates for Patients on Assisted Peritoneal Dialysis Compared with In-Center Hemodialysis

Oliver

Al-Jaishi

Dixon

et al. 2016

CJASN

Self Cite

View full text Add to dashboard Cite

Background and objectives Assisted peritoneal dialysis is a treatment option for individuals with barriers to selfcare who wish to receive home dialysis, but previous research suggests that this treatment modality is associated with a higher rate of hospitalization. The objective of our study was to determine whether assisted peritoneal dialysis has a different rate of hospital days compared to in-center hemodialysis.

show abstract

“…Although various guidelines and papers differ with respect to potential contraindications for PD (Table 2), [3][4][5][6][7] clinical evidence of ineligibility for PD in these particular circumstances is often lacking. It is our opinion that very few medical contraindications exist for PD.…”

Section: Peritoneal Dialysis: Who?mentioning

confidence: 99%

Evaluating the benefits of home-based peritoneal dialysis

François¹,

Bargman²

2014

IJNRD

View full text Add to dashboard Cite

Peritoneal dialysis (PD) is an effective renal replacement strategy for patients suffering from end-stage renal disease. PD offers patient survival comparable to or better than in-center hemodialysis while preserving residual kidney function, empowering patient autonomy, and reducing financial burden to payors. The majority of patients suffering from kidney failure are eligible for PD. In patients with cardiorenal syndrome and uncontrolled fluid status, PD is of particular benefit, decreasing hospitalization rates and duration. This review discusses the benefits of chronic PD, performed by the patient or a caregiver at home. Recognition of the benefits of PD is a cornerstone in stimulating the use of this treatment strategy.

show abstract

Peritoneal Dialysis and the Process of Modality Selection

Cited by 74 publications

References 24 publications

Incremental peritoneal dialysis: a 10 year single-centre experience

Incremental peritoneal dialysis: a 10 year single-centre experience

Hospitalization Rates for Patients on Assisted Peritoneal Dialysis Compared with In-Center Hemodialysis

Evaluating the benefits of home-based peritoneal dialysis

Contact Info

Product

Resources

About